BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1374 related articles for article (PubMed ID: 16755209)

  • 1. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension.
    Park MH
    Catheter Cardiovasc Interv; 2008 Feb; 71(2):205-13. PubMed ID: 18327839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?
    Pitsiou GG; Chavouzis N; Nakou C; Boutou AK; Argyropoulou P; Stanopoulos I
    J Heart Lung Transplant; 2009 Jun; 28(6):651-3. PubMed ID: 19481029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil in the treatment of pulmonary hypertension.
    Barnett CF; Machado RF
    Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin antagonism in pulmonary arterial hypertension.
    Lee SH; Channick RN
    Semin Respir Crit Care Med; 2005 Aug; 26(4):402-8. PubMed ID: 16121317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
    Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
    Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract]   [Full Text] [Related]  

  • 10. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
    Beghetti M; Galiè N
    J Am Coll Cardiol; 2009 Mar; 53(9):733-40. PubMed ID: 19245962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pulmonary arterial hypertension.
    Humbert M; Sitbon O; Simonneau G
    N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination drug therapy in the management of pulmonary arterial hypertension.
    Kayser SR
    Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pulmonary arterial hypertension and systemic sclerosis].
    Launay D; Humbert M; Hachulla E
    Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil for pulmonary hypertension.
    Lee AJ; Chiao TB; Tsang MP
    Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
    Montani D; Humbert M
    Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.
    Wilkens H; Guth A; König J; Forestier N; Cremers B; Hennen B; Böhm M; Sybrecht GW
    Circulation; 2001 Sep; 104(11):1218-22. PubMed ID: 11551870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update in the diagnosis and therapy for pulmonary arterial hypertension].
    Zagolin B M; Wainstein G E; Uriarte G P
    Rev Med Chil; 2006 Jul; 134(7):902-9. PubMed ID: 17130975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for pulmonary arterial hypertension.
    Liu C; Liu K; Ji Z; Liu G
    Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment for pulmonary arterial hypertension.
    Sastry BK
    Curr Opin Cardiol; 2006 Nov; 21(6):561-8. PubMed ID: 17053404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.